Search

Your search keyword '"Bourdon, Violaine"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Bourdon, Violaine" Remove constraint Author: "Bourdon, Violaine"
151 results on '"Bourdon, Violaine"'

Search Results

2. Arabidopsis Mutants Impaired in Cosuppression

3. Supplementary Data from Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12

4. Supplementary Tables from Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System

5. Data from Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12

6. Supplementary Data Tables S1-S4 from Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12

7. Data from Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System

8. Supplementary Data from Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System

11. Familial hematological malignancies: new IDH2 mutation

12. Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies

13. A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

14. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

15. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort (vol 46, pg 7913, 2018)

16. Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer

19. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

20. Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System

21. Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12

24. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

26. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

29. Etude de COségrégation familiale des VARiants nucléotidiques (COVAR) dans les gènes BRCA1/2 pour valider leur utilisation en conseil génétique

30. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort

31. Molecular study of the perforin gene in familial hematological malignancies

32. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis

33. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort

34. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort (vol 46, pg 7913, 2018)

36. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort

37. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

38. ARLTS1, potential candidate gene in familial aggregation of hematological malignancies

39. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

41. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

42. Perforin-1 does not appear to be associated with familial hematological malignancies

44. Développement d'une stratégie de criblage du gène MECP2 chez des patientes atteintes d'un syndrôme de Rett : mise en évidence d'un spectre hétérogène de mutations

46. Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67

48. Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application toMLH1germline mutations in Lynch syndrome

50. Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Catalog

Books, media, physical & digital resources